Clinical Trial Update: Intratympanic Injection for Autoimmune Inner Ear Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of an intratympanic injection for autoimmune inner ear disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Inner Ear Disease

Snippet

Sponsor: House Research Institute | Conditions: Autoimmune Inner Ear Disease | Phase 1, Phase 2 | Status: TERMINATED